Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E, particularly in the form of alpha-tocopherol, has been investigated for its potential role in preventing or slowing the progression of cataracts due to its antioxidant properties. The rationale is that oxidative stress contributes to cataract formation by damaging the proteins and lipids in the lens of the eye, and antioxidants like Vitamin E could theoretically help neutralize free radicals and reduce this damage.

Several observational studies have suggested that higher dietary intake or blood levels of Vitamin E may be associated with a lower risk of developing cataracts. For example, some large population-based studies have reported a modestly lower incidence of cataracts among people with higher Vitamin E consumption. However, randomized controlled trials (RCTs) have generally not confirmed a significant protective effect. Notably, the Age-Related Eye Disease Study (AREDS) and subsequent trials found that Vitamin E supplementation, alone or in combination with other antioxidants, did not significantly reduce the risk of cataract development or progression.

Therefore, while there is some biological plausibility and limited epidemiological support for Vitamin E in cataract prevention, high-quality clinical trial evidence does not support its routine use for this purpose. The overall scientific evidence is weak (2/5), and current ophthalmology guidelines do not recommend Vitamin E supplements specifically for cataract prevention or treatment.

More about Vitamin E (alpha-tocopheryl hydrochloride)
More about Cataracts

Other ingredients used for Cataracts

Other health conditions supported by Vitamin E (alpha-tocopheryl hydrochloride)

Products containing Vitamin E (alpha-tocopheryl hydrochloride)